Entities / Company
Daiichi.
supermarket in Obihiro, Hokkaido, Japan
- Reports this week
- 0
- Active events
- 0
- Connections
- 7
What's happening
Gone quiet
No new reports in 90+ days-
Merck and Daiichi began a Phase III study after Merck acquired co-development rights from Daiichi.Some support2 reports1 development inside
-
Merck and Daiichi successfully advanced an ADC through co-development, gaining Breakthrough Therapy designation from the FDA and orphan drug status in Europe.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Daiichi this week
News at the entities that move Daiichi most-
FDA StructuralClene Inc. submitted an NDA to the FDA seeking accelerated approval while trading on the Nasdaq exchange.Moves Daiichi
-
AstraZeneca OperationalAstraZeneca is relocating its registered office from Karnataka to Bengaluru, citing proximity to policy and financial ecosystems.Moves Daiichi
-
Merck OperationalThe Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.Moves Daiichi
Connections
The 3 strongest of 7, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AstraZeneca Operational
AstraZeneca and Daiichi are engaged in a formal partnership for joint drug development and marketing.
-
Merck Operational
Merck and Daiichi are engaged in a formal co-development partnership for a Phase III clinical study following the acquisition of co-development rights.
-
FDA Structural
FDA's regulatory data requirements dictate whether Daiichi can achieve accelerated product clearance.